(AMJB) JPMorgan Chase Financial - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US48133Q3092 • Energy Limited Partnership

AMJB: Energy, Pipeline, Storage, Transportation, Infrastructure, Services

JPMorgan Chase Financial Company LLC (NYSE ARCA: AMJB) is an exchange-traded fund (ETF) designed to track the performance of master limited partnerships (MLPs) primarily engaged in qualified energy commodity activities. These activities include compression, gathering, processing, liquefaction, marketing, pipeline transportation, rail termination, and storage of energy commodities. The fund employs a capped, float-adjusted, capitalization-weighted methodology to ensure diversified exposure to the energy sector while mitigating concentration risk. By focusing on MLPs that generate the majority of their cash flows from these qualified activities, the ETF provides investors with targeted access to the energy infrastructure and midstream sectors.

The ETF is listed on the NYSE ARCA under the ticker symbol AMJB and is categorized as an Energy Limited Partnership ETF. It is structured as a U.S.-domiciled investment vehicle, offering exposure to a portfolio of MLPs that operate critical infrastructure for the transportation, storage, and processing of energy commodities. The funds composition is designed to reflect the performance of the underlying index, which is weighted by market capitalization with a cap to ensure no single component dominates the portfolio.

Based on the technical and fundamental data, the ETF is currently trading below its 20-day and 50-day simple moving averages (SMAs), which stand at 29.46 and 30.93, respectively. However, it is slightly above its 200-day SMA of 29.43, indicating a potential long-term support level. The average true range (ATR) of 0.86 suggests moderate volatility, while the average 20-day volume of 42,450 shares indicates relatively stable trading activity. With assets under management (AUM) of $777.73 million, the fund maintains a solid scale, which is positive for liquidity and tracking efficiency. Overall, the ETFs short-term outlook appears bearish due to its position below key SMAs, but its long-term trajectory may stabilize as it remains near its 200-day average.

Additional Sources for AMJB ETF

AMJB ETF Overview

Market Cap in USD 778m
Category Energy Limited Partnership
TER 0.85%
IPO / Inception 2024-01-26

AMJB ETF Ratings

Growth Rating 49.8
Fundamental -
Dividend Rating 41.1
Rel. Strength 20.5
Analysts -
Fair Price Momentum 26.78 USD
Fair Price DCF -

AMJB Dividends

Dividend Yield 12m 6.30%
Yield on Cost 5y 7.38%
Annual Growth 5y -48.17%
Payout Consistency 100.0%

AMJB Growth Ratios

Growth Correlation 3m -60.7%
Growth Correlation 12m 83.6%
Growth Correlation 5y 90.7%
CAGR 5y 14.90%
CAGR/Max DD 5y 0.88
Sharpe Ratio 12m 0.74
Alpha 0.49
Beta 0.682
Volatility 22.84%
Current Volume 35.7k
Average Volume 20d 42.5k
What is the price of AMJB stocks?
As of May 09, 2025, the stock is trading at USD 29.48 with a total of 35,729 shares traded.
Over the past week, the price has changed by +0.55%, over one month by +7.67%, over three months by -8.61% and over the past year by +9.08%.
Is JPMorgan Chase Financial a good stock to buy?
Partly, yes. Based on ValueRay Analyses, JPMorgan Chase Financial (NYSE ARCA:AMJB) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.79 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMJB as of May 2025 is 26.78. This means that AMJB is currently overvalued and has a potential downside of -9.16%.
Is AMJB a buy, sell or hold?
JPMorgan Chase Financial has no consensus analysts rating.
What are the forecast for AMJB stock price target?
According to ValueRays Forecast Model, AMJB JPMorgan Chase Financial will be worth about 29.9 in May 2026. The stock is currently trading at 29.48. This means that the stock has a potential upside of +1.26%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.9 1.3%